Changes in cervical cancer FDG uptake during chemoradiation and association with response

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 1, 2013, Pages 116-122

  Kidd, Elizabeth A ^a   Thomas, Maria ^b   Siegel, Barry A ^c,d   Dehdashti, Farrokh ^c,d   Grigsby, Perry W ^b,c,d  

^a STANFORD CANCER INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERVICAL CANCERS; CHEMORADIATION; CONCURRENT CHEMORADIATION; EMISSION TOMOGRAPHY; FASTER RATES; FDG-PET; FLUORODEOXYGLUCOSE; PILOT STUDIES; POST TREATMENT; PRE-TREATMENT; STANDARDIZED UPTAKE VALUES; TIME POINTS; TUMOR VOLUMES;

CHEMORADIOTHERAPY; POSITRON EMISSION TOMOGRAPHY; TUMORS;

COMPUTERIZED TOMOGRAPHY;

ANTINEOPLASTIC AGENT; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LONG TERM SURVIVAL; METABOLIC TUMOR VOLUME; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84871375137     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.056     Document Type: Article

References (20)

1. P.J. Eifel, K. Winter, and M. Morris Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880 (Pubitemid 41103599)
2. Schwarz JK, Siegel BA, Dehdashti F, et al. Metabolic response on posttherapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys (in press); [Epub ahead of print 2011 Oct 17].
3. E.A. Kidd, B.A. Siegel, and F. Dehdashti The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 2007 1738 1744 (Pubitemid 47557298)
4. E.A. Kidd, and P.W. Grigsby Intratumoral metabolic heterogeneity of cervical cancer Clin Cancer Res 14 2008 5236 5241
5. T.R. Miller, and P.W. Grigsby Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy Int J Radiat Oncol Biol Phys 53 2002 353 359 (Pubitemid 34522101)
6. J.K. Schwarz, B.A. Siegel, and F. Dehdashti Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma JAMA 298 2007 2289 2295 (Pubitemid 350146219)
7. J.M. Rozental, R.L. Levine, and R.J. Nickles Glucose uptake by gliomas after treatment. A positron emission tomographic study Arch Neurol 46 1989 1302 1307 (Pubitemid 20013362)
8. U. Haberkorn, M. Reinhardt, and L.G. Strauss Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy J Nucl Med 33 1992 1981 1987
9. F.M. Kong, K.A. Frey, and L.E. Quint A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer J Clin Oncol 25 2007 3116 3123 (Pubitemid 47218060)
10. H.A. Wieder, B.L. Brucher, and F. Zimmermann Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 2004 900 908 (Pubitemid 41103602)
11. M. Bjurberg, E. Kjellen, and T. Ohlsson Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer Int J Gynecol Cancer 19 2009 1600 1605
12. A. van Baardwijk, G. Bosmans, and A. Dekker Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients Radiother Oncol 82 2007 145 152
13. H.J. Aerts, G. Bosmans, and A.A. van Baardwijk Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study Int J Radiat Oncol Biol Phys 71 2008 1402 1407
14. J. van den Bogaard, M.H. Janssen, and G. Janssens Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer Radiother Oncol 99 2011 137 141
15. L.L. Lin, Z. Yang, and S. Mutic FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer Int J Radiat Oncol Biol Phys 65 2006 177 181
16. H. Young, R. Baum, and U. Cremerius Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 35 1999 1773 1782 (Pubitemid 29512308)
17. P. Price, and T. Jones Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group Eur J Cancer 31A 1995 1924 1927 (Pubitemid 26023081)
18. J.K. Schwarz, L.L. Lin, and B.A. Siegel 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer Int J Radiat Oncol Biol Phys 72 2008 1502 1507
19. F.J. Brooks, and P.W. Grigsby Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome Radiat Oncol 6 2011 69
20. M.H. Janssen, M.C. Ollers, and R.G. Riedl Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging Int J Radiat Oncol Biol Phys 77 2010 392 399